Skip to content
OpenCapital
Get started

Revvity RVTY Life Sciences — Depreciation

Other segment segments

Diagnostics
$9.49M-17.7%

Similar metrics at other companies

Labcorp Holdings logo
LHBiopharma Laboratory Services — Depreciation
$28.6M0.0%
STERIS logo
STEHealthcare Products and Life Sciences — Depreciation, Depletion and Amortization
$81.9M-4.5%
Baxter International logo
BAXHealthcare Systems & Technologies — Depreciation
$24M-11.1%
Bio-Rad Laboratories logo
BIO.BLife Science — Depreciation, Depletion and Amortization
——
PEA
PEAKLifescience — Depreciation And Amortization
——
PEA
PEAKLife Science — Depreciation and amortization of real estate, in-place lease, and other intangibles
——

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%—
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's life sciences — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's life sciences — depreciation?
Revvity (RVTY) reported life sciences — depreciation of $9.91M in Q1 2026.
How has Revvity's life sciences — depreciation changed year-over-year?
Revvity's life sciences — depreciation increased by 37.9% year-over-year, from $7.19M to $9.91M.
What is the long-term trend for Revvity's life sciences — depreciation?
Over 3 years (2022 to 2025), Revvity's life sciences — depreciation has grown at a 11.0% compound annual growth rate (CAGR), from $24.51M to $33.49M.
What does life sciences — depreciation mean?
The annual expense for the wear and tear of Life Sciences equipment.
How do you interpret life sciences — depreciation?
High depreciation relative to revenue may indicate a capital-intensive business model or recent heavy investment in infrastructure.
How does life sciences — depreciation compare across companies?
Standard non-cash expense reported in cash flow and segment notes for capital-intensive industries.